UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 24,
Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Hepion Pharmaceuticals Charts.
Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Hepion Pharmaceuticals Charts.

Hepion Pharmaceuticals, Inc. News

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Saturday 20 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Form 8-K - Current report
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
Saturday 17 February 2024 (3 months ago) • GlobeNewswire Inc.
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Hepion Pharmaceuticals to Present at NASH-TAG 2024
Thursday 4 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
Friday 8 December 2023 (5 months ago) • GlobeNewswire Inc.
Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Wednesday 29 November 2023 (5 months ago) • GlobeNewswire Inc.
Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
Tuesday 14 November 2023 (6 months ago) • GlobeNewswire Inc.
Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
Saturday 11 November 2023 (6 months ago) • GlobeNewswire Inc.
Form EFFECT - Notice of Effectiveness
Thursday 9 November 2023 (6 months ago) • Edgar (US Regulatory)
Hepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
Wednesday 25 October 2023 (6 months ago) • GlobeNewswire Inc.

More Hepion Pharmaceuticals, Inc. News Articles